Carcinoma, Non-Small-Cell Lung: all 6,645 studies
Page 43 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.
- Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation TherapyActive, not recruitingNCT04085250Phase 2
- Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family CaregiversWithdrawnNCT04085081Not applicable
- Study of Crizotinib for ROS1 and MET Activated Lung CancerCompletedNCT04084717Phase 2
- GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsActive, not recruitingNCT04083599Phase 1/2
- Early Response Evaluation in NSCLC Patients Treated With ImmunotherapyTerminatedNCT04082988Not applicable
- MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung CancerStatus unknownNCT04082182Phase 1
- MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung CancerCompletedNCT04078269Phase 1
- A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerActive, not recruitingNCT04077463Phase 1
- A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerActive, not recruitingNCT04077099Phase 1/2
- Biomarkers to Predict the Response to Pembrolizumab in Chinese NSCLC PatientsCompletedNCT04076228
- Brigatinib in ALK-positive NSCLC Identified Via Blood-based AssaysActive, not recruitingNCT04074993Phase 2
- Study of ARRY-614 Plus Either Nivolumab or Nivolumab+IpilimumabActive, not recruitingNCT04074967Phase 1/2
- Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerActive, not recruitingNCT04073745Phase 1
- Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung CancerStatus unknownNCT04073537Phase 3
- Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLCTerminatedNCT04069936Phase 2
- Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational StudyCompletedNCT04069663
- cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsWithdrawnNCT04069442
- Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion MutationStatus unknownNCT04063462Phase 2
- Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerWithdrawnNCT04061590Phase 2
- Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]CompletedNCT04059887Phase 4
- Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene SulfonateStatus unknownNCT04059874Phase 1
- Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibStatus unknownNCT04056572Phase 2
- Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer TreatmentsActive, not recruitingNCT04056247
- Study of KN046 With Chemotherapy in First Line Advanced NSCLCStatus unknownNCT04054531Phase 2
- To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET DysregulationCompletedNCT04052971Phase 1
- Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung CancerStatus unknownNCT04052412Phase 1
- A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsCompletedNCT04045496Phase 1
- ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)Active, not recruitingNCT04044859Phase 1
- Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion MutationTerminatedNCT04044170Phase 2
- DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung CancerActive, not recruitingNCT04042701Phase 1
- Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During PrehabilitationCompletedNCT04041297
- Circulating DNA in Surgically Treated NSCLCStatus unknownNCT04037150
- A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerActive, not recruitingNCT04036682Phase 1/2
- A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLCActive, not recruitingNCT04033354Phase 3
- Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790MStatus unknownNCT04029350Phase 2
- Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLCStatus unknownNCT04028778Phase 3
- Phase 2 Study of Dacomitinib in NSCLCActive, not recruitingNCT04027647Phase 2
- Molecular Profiling ProjectSuspendedNCT04025515
- Stage III NSCLC RWE in Chinese PatientsCompletedNCT04023812
- A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLCStatus unknownNCT04023617Phase 2
- The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung CancerCompletedNCT04018183
- A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in ChinaActive, not recruitingNCT04015778Phase 2
- Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung CancerActive, not recruitingNCT04013542Phase 1
- Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT04009317Phase 3
- Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206CompletedNCT04009122Not applicable
- Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKIStatus unknownNCT04007835Not applicable
- Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsActive, not recruitingNCT04007744Phase 1
- First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C MutationCompletedNCT04006301Phase 1
- Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung CancerTerminatedNCT04005144Phase 1
- Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesTerminatedNCT04000529Phase 1
- Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung CancerActive, not recruitingNCT03999710Phase 2
- Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLCStatus unknownNCT03998085Not applicable
- Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung CancerStatus unknownNCT03997799Not applicable
- Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLCCompletedNCT03995875
- Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.Status unknownNCT03994393Phase 2
- Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in METActive, not recruitingNCT03993873Phase 1
- Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLCStatus unknownNCT03991403Phase 3
- Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLCTerminatedNCT03990077Phase 1
- Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint InhibitorsWithdrawnNCT03989050
- Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic ResponseTerminatedNCT03988192Not applicable
- Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLCStatus unknownNCT03987867Phase 1
- Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsSuspendedNCT03987555
- A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLCStatus unknownNCT03987087Phase 2
- Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03986528Phase 4
- PDR001 + Panobinostat for Melanoma and NSCLCWithdrawnNCT03982134Phase 1
- Safety and Efficacy of Genolimzumab (GB226) in Combination With FruquintinibStatus unknownNCT03976856Phase 1
- Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)CompletedNCT03976518Phase 2
- A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5)Status unknownNCT03975114Phase 2
- Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03972189Phase 2
- Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLCStatus unknownNCT03971175Not applicable
- Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCActive, not recruitingNCT03970746Phase 1/2
- Whole Genomic Landscape of Advanced EGFR-mutant NSCLCActive, not recruitingNCT03969823Not applicable
- Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLCActive, not recruitingNCT03965468Phase 2
- Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung CancerCompletedNCT03958097Phase 2
- A Safety Study of SGN-CD47M in Patients With Solid TumorsTerminatedNCT03957096Phase 1
- Evolution of the Physical Condition in Treated Cancer PatientsStatus unknownNCT03956641Not applicable
- A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following ChemoradiationCompletedNCT03955198Phase 2
- A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT03952403Phase 3
- K-RAS and EGFR in Lung CancerCompletedNCT03951233
- Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC ImmunotherapyTerminatedNCT03951012
- Clinical Trial for Evaluating Efficacy and Safety of PDR001 in Concurrent Plus Consolidation Versus Consolidation Only in Addition to Standard Chemoradiotherapy in Unresectable Stage III NSCLC Patients (PASTURE)WithdrawnNCT03945227Phase 2
- Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)Active, not recruitingNCT03944772Phase 2
- Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung CancerCompletedNCT03944265Not applicable
- CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor HistologyStatus unknownNCT03940846
- Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerActive, not recruitingNCT03937154Phase 3
- Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection SurgeryCompletedNCT03936764Not applicable
- Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNACompletedNCT03926260Not applicable
- Assessment of Ergonomics in 3D vs 2D Thoracoscopic LobectomyCompletedNCT03925103Not applicable
- Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKICompletedNCT03924050Phase 3
- A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT03922997Phase 3
- Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung CancerStatus unknownNCT03921957Not applicable
- INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)WithdrawnNCT03920839Phase 1
- Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUSCompletedNCT03918304
- TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLCStatus unknownNCT03916913Not applicable
- Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult PatientsActive, not recruitingNCT03916627Phase 2
- CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung CancerCompletedNCT03916367
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive, not recruitingNCT03915678Phase 2
- Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLCStatus unknownNCT03912389Phase 3
- CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET DeregulationStatus unknownNCT03911193Phase 2
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）Status unknownNCT03910127Phase 1